PriceTargets.com logo

GoHealth - GOCO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.67
  • Forecasted Upside: -31.45%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$15.56 As of 03/30/2023 01:00 AM ET
▲ +0.47 (3.11%)

This chart shows the closing price for GOCO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New GoHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GOCO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GOCO

Analyst Price Target is $10.67
▼ -31.45% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for GoHealth in the last 3 months. The average price target is $10.67, with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a -31.45% upside from the last price of $15.56.

This chart shows the closing price for GOCO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in GoHealth. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
10/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
1/4/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
4/4/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
7/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
10/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/17/2023Bank of AmericaBoost Target$9.75 ➝ $11.00Low
3/17/2023Royal Bank of CanadaLower TargetSector Perform$15.00 ➝ $14.00Low
11/24/2022Credit Suisse GroupSet Target$7.00Low
8/16/2022Credit Suisse GroupLower TargetUnderperform$1.50 ➝ $1.25Low
3/17/2022Credit Suisse GroupLower Target$3.00 ➝ $1.50High
3/16/2022Evercore ISILower TargetIn-Line$4.50 ➝ $1.75High
3/3/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$10.00 ➝ $2.00High
3/2/2022Truist FinancialDowngradeBuy ➝ Hold$2.00High
1/7/2022Credit Suisse GroupDowngradeNeutral ➝ Underperform$6.00 ➝ $3.00High
1/5/2022Bank of AmericaDowngradeBuy ➝ Underperform$7.50 ➝ $3.50High
11/15/2021Credit Suisse GroupLower TargetNeutral$7.00 ➝ $6.00Low
11/11/2021Morgan StanleyLower TargetEqual Weight$13.00 ➝ $5.50High
11/10/2021Royal Bank of CanadaLower TargetOutperform$17.00 ➝ $10.00High
11/9/2021BarclaysDowngradeOverweight ➝ Equal Weight$10.00 ➝ $5.00High
8/13/2021BarclaysLower TargetOverweight$18.00 ➝ $10.00High
8/12/2021Cantor FitzgeraldReiterated RatingOverweightHigh
8/12/2021Morgan StanleyLower TargetEqual Weight$14.00 ➝ $13.00High
8/12/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$18.00 ➝ $10.00High
8/12/2021Raymond JamesDowngradeOutperform ➝ Market PerformHigh
5/17/2021Raymond JamesLower TargetOutperform$15.00 ➝ $14.00Medium
5/17/2021Credit Suisse GroupLower TargetOutperform$19.00 ➝ $18.00Medium
5/14/2021Morgan StanleyBoost TargetEqual Weight$13.00 ➝ $14.00High
5/13/2021Truist FinancialLower TargetBuy ➝ Buy$26.00 ➝ $20.00Medium
3/15/2021Raymond JamesLower TargetOutperform$18.00 ➝ $15.00High
3/10/2021Morgan StanleyLower TargetEqual Weight$14.00 ➝ $13.00High
3/9/2021Credit Suisse GroupLower TargetOutperform$21.00 ➝ $19.00High
11/16/2020Credit Suisse GroupLower TargetOutperform$25.00 ➝ $21.00Medium
11/12/2020Evercore ISILower TargetOutperform$27.00 ➝ $25.00High
11/12/2020Raymond JamesReiterated RatingBuyHigh
11/12/2020Morgan StanleyLower TargetEqual Weight$18.00 ➝ $14.00High
10/2/2020Raymond JamesInitiated CoverageOutperform$18.00 ➝ $18.00High
8/20/2020Credit Suisse GroupReiterated RatingBuy$25.00Medium
8/20/2020Morgan StanleyBoost TargetEqual Weight$17.00 ➝ $18.00High
8/11/2020William BlairInitiated CoverageOutperformHigh
8/10/2020Royal Bank of CanadaInitiated CoverageOutperform$22.00High
8/10/2020Truist FinancialInitiated CoverageBuyHigh
8/10/2020Bank of AmericaInitiated CoverageBuy$22.00High
8/10/2020Cantor FitzgeraldInitiated CoverageOverweight$26.00High
8/10/2020Credit Suisse GroupInitiated CoverageOutperform$25.00High
8/10/2020Morgan StanleyInitiated CoverageEqual Weight$17.00High
8/10/2020BarclaysInitiated CoverageOverweight$22.00High
8/10/2020The Goldman Sachs GroupInitiated CoverageBuy$21.00High
8/9/2020Evercore ISIInitiated CoverageOutperform$27.00Low
(Data available from 3/30/2018 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
9/1/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2022
  • 5 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2023

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

GoHealth logo
GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.
Read More

Today's Range

Now: $15.56
Low: $14.73
High: $15.86

50 Day Range

MA: $16.02
Low: $13.22
High: $19.10

52 Week Range

Now: $15.56
Low: $4.93
High: $20.70

Volume

26,048 shs

Average Volume

50,961 shs

Market Capitalization

$341.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Frequently Asked Questions

What sell-side analysts currently cover shares of GoHealth?

The following sell-side analysts have issued research reports on GoHealth in the last twelve months: Bank of America Co., Credit Suisse Group AG, and Royal Bank of Canada.
View the latest analyst ratings for GOCO.

What is the current price target for GoHealth?

3 Wall Street analysts have set twelve-month price targets for GoHealth in the last year. Their average twelve-month price target is $10.67, suggesting a possible downside of 31.4%. Royal Bank of Canada has the highest price target set, predicting GOCO will reach $14.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $7.00 for GoHealth in the next year.
View the latest price targets for GOCO.

What is the current consensus analyst rating for GoHealth?

GoHealth currently has 1 sell rating and 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GOCO, but not buy more shares or sell existing shares.
View the latest ratings for GOCO.

What other companies compete with GoHealth?

Other companies that are similar to GoHealth include SelectQuote, eHealth, Fanhua, Horizon Technology Finance and LendingTree. Learn More about companies similar to GoHealth.

How do I contact GoHealth's investor relations team?

GoHealth's physical mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The company's listed phone number is 312-386-8200 and its investor relations email address is [email protected] The official website for GoHealth is www.gohealth.com. Learn More about contacing GoHealth investor relations.